1. Home
  2. LPCN vs YHGJ Comparison

LPCN vs YHGJ Comparison

Compare LPCN & YHGJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPCN
  • YHGJ
  • Stock Information
  • Founded
  • LPCN 1997
  • YHGJ 1975
  • Country
  • LPCN United States
  • YHGJ United States
  • Employees
  • LPCN N/A
  • YHGJ N/A
  • Industry
  • LPCN Biotechnology: Pharmaceutical Preparations
  • YHGJ Specialty Chemicals
  • Sector
  • LPCN Health Care
  • YHGJ Industrials
  • Exchange
  • LPCN Nasdaq
  • YHGJ Nasdaq
  • Market Cap
  • LPCN 16.1M
  • YHGJ 15.8M
  • IPO Year
  • LPCN N/A
  • YHGJ 1997
  • Fundamental
  • Price
  • LPCN $3.10
  • YHGJ $0.95
  • Analyst Decision
  • LPCN Strong Buy
  • YHGJ
  • Analyst Count
  • LPCN 1
  • YHGJ 0
  • Target Price
  • LPCN $10.00
  • YHGJ N/A
  • AVG Volume (30 Days)
  • LPCN 10.3K
  • YHGJ 42.7K
  • Earning Date
  • LPCN 05-08-2025
  • YHGJ 04-15-2025
  • Dividend Yield
  • LPCN N/A
  • YHGJ N/A
  • EPS Growth
  • LPCN N/A
  • YHGJ N/A
  • EPS
  • LPCN N/A
  • YHGJ N/A
  • Revenue
  • LPCN $11,198,144.00
  • YHGJ $17,953,000.00
  • Revenue This Year
  • LPCN N/A
  • YHGJ N/A
  • Revenue Next Year
  • LPCN N/A
  • YHGJ N/A
  • P/E Ratio
  • LPCN N/A
  • YHGJ N/A
  • Revenue Growth
  • LPCN N/A
  • YHGJ 0.84
  • 52 Week Low
  • LPCN $2.75
  • YHGJ $0.43
  • 52 Week High
  • LPCN $11.79
  • YHGJ $1.66
  • Technical
  • Relative Strength Index (RSI)
  • LPCN 46.56
  • YHGJ 44.39
  • Support Level
  • LPCN $2.82
  • YHGJ $0.96
  • Resistance Level
  • LPCN $3.27
  • YHGJ $1.15
  • Average True Range (ATR)
  • LPCN 0.23
  • YHGJ 0.10
  • MACD
  • LPCN 0.01
  • YHGJ -0.02
  • Stochastic Oscillator
  • LPCN 58.92
  • YHGJ 16.62

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

About YHGJ Yunhong Green CTI Ltd.

Yunhong Green CTI Ltd manufactures and marketers of foil balloons and produces laminated and printed films for commercial uses. The company also distributes balloon-inspired and other gift items, and continues development of compostable material solutions, and markets its products throughout the United States and in several other countries.

Share on Social Networks: